Tien-Li Lee Buys 16,542 Shares of Aardvark Therapeutics, Inc. (NASDAQ:AARD) Stock

Aardvark Therapeutics, Inc. (NASDAQ:AARD) CEO Tien-Li Lee bought 16,542 shares of the business’s stock in a transaction on Friday, February 14th. The stock was purchased at an average price of $16.00 per share, for a total transaction of $264,672.00. Following the completion of the acquisition, the chief executive officer now owns 1,496,175 shares of the company’s stock, valued at approximately $23,938,800. This trade represents a 1.12 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Aardvark Therapeutics Stock Up 15.8 %

AARD opened at $17.25 on Friday. Aardvark Therapeutics, Inc. has a 12 month low of $11.55 and a 12 month high of $19.58.

About Aardvark Therapeutics

We are a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. We target biological pathways associated with alleviating hunger that we believe have the potential to deliver transformative outcomes for patients.